Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice

Hepatology

Volumn 58, Issue 6, 2013, Pages 2056-2069

  Fickert, Peter ^a   Krones, Elisabeth ^a   Pollheimer, Marion J ^a   Thueringer, Andrea ^a   Moustafa, Tarek ^a   Silbert, Dagmar ^a   Halilbasic, Emina ^g   Yang, Min ^b   Jaeschke, Hartmut ^b   Stokman, Geurt ^c   Wells, Rebecca G ^d   Eller, Kathrin ^a   Rosenkranz, Alexander R ^a   Eggertsen, Gosta ^e   Wagner, Carsten A ^f   Langner, Cord ^a   Denk, Helmut ^a   Trauner, Michael ^g  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; BILE ACID; FARNESOID X RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UREA; URSODEOXYCHOLIC ACID; VASCULAR CELL ADHESION MOLECULE 1; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BILE DUCT LIGATION; CHOLESTASIS; COMMON BILE DUCT; CONTROLLED STUDY; INTERSTITIAL NEPHRITIS; KIDNEY COLLECTING TUBULE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY MASS; KIDNEY SIZE; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UREA BLOOD LEVEL; URINARY CAST; URINE VOLUME; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; GENETICS; KIDNEY DISEASE; KIDNEY TUBULE; KNOCKOUT MOUSE; LIGATION; NEPHRITIS, INTERSTITIAL;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTASIS; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; KIDNEY DISEASES; KIDNEY TUBULES; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS, INTERSTITIAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; URSODEOXYCHOLIC ACID;

EID: 84888303010     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26599     Document Type: Article

References (51)

1. Fede G, D'Amico G, Arvaniti V, Tsochatzis E, Germani G, Georgiadis D, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol 2012;56:810-818.
2. Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011;60:702-709.
3. Trawalé JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallée M, et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int 2010;30:725-732.
4. Uslu A, Taşli FA, Nart A, Postaci H, Aykas A, Bati H, Coşkun Y. Human kidney histopathology in acute obstructive jaundice: a prospective study. Eur J Gastroenterol Hepatol 2010;22:1458-1465.
5. Montini G, Carasi C, Zancan L, Dall'Amico R, Murer L, Zacchello G, Sorino P. Chronic cholestatic liver disease with associated tubulointerstitial nephropathy in early childhood. Pediatrics 1997;100:E10.
6. Popović-Rolović M, Kostić M, Sindjić M, Jovanović O, Peco-Antić A, Kruscić D. Progressive tubulointerstitial nephritis and chronic cholestatic liver disease. Pediatr Nephrol 1993;7:396-400.
7. Dawson JL. The incidence of postoperative renal failure in obstructive jaundice. Br J Surg 1965;52:663-665.
8. Armstrong CP, Dixon JM, Taylor TV, Davies GC. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984;71:234-238.
9. Betjes MG, Bajema I. The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited. J Nephrol 2006;19:229-233.
10. Zollner G, Trauner M. Mechanisms of cholestasis. Clin Liver Dis 2008;12:1-26.
11. Wilkinson SP, Moodie H, Stamatakis JD, Kakkar VV, Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 1976;2:1415-1418.
12. Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 2006;290:G923-G932.
13. Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T, et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol 2006;290:G1124-G1130.
14. Kramer HJ. Impaired renal function in obstructive jaundice: roles of the thromboxane and endothelin systems. Nephron 1997;77:1-12.
15. Bomzon A, Holt S, Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 1997;17:549-562.
16. Panozzo MP, Basso D, Balint L, Zaninotto M, Bonvicini P, Plebani M. Renal functional alterations in extrahepatic cholestasis: can oxidative stress be involved? Eur Surg Res 1995;27:332-339.
17. Parks RW, Rowlands BJ. Renal dysfunction and endotoxaemia in obstructive jaundice. Natl Med J India 1995;8:249-251.
18. Terg R, Gadano A, Cartier M, Casciato P, Lucero R, Muñoz A, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int 2009;29:415-419.
19. Ackermann D, Mordasini D, Cheval L, Imbert-Teboul M, Vogt B, Doucet A. Sodium retention and ascites formation in a cholestatic mice model: role of aldosterone and mineralocorticoid receptor? Hepatology 2007;46:173-179.
20. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-1251.
21. Mohebbi N, Perna A, van der Wijst J, Becker HM, Capasso G, Wagner CA. Regulation of two renal chloride transporters, AE1 and pendrin, by electrolytes and aldosterone. PLoS One 2013;8:e55286.
22. - excretion but also by systemic metabolic acidosis. Am J Physiol Cell Physiol 2008;295:C1658-C1667.
23. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001;121:170-183.
24. Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O, et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003;125:825-838.
25. Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A 1993;90:11663-11667.
26. Brown D, Breton S, Ausiello DA, Marshansky V. Sensing, signaling and sorting events in kidney epithelial cell physiology. Traffic 2009;10:275-284.
27. Kim J, Kim YH, Cha JH, Tisher CC, Madsen KM. Intercalated cell subtypes in connecting tubule and cortical collecting duct of rat and mouse. J Am Soc Nephrol 1999;10:1-12.
28. Marschall HU, Wagner M, Bodin K, Zollner G, Fickert P, Gumhold J, et al. Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 2006;47:582-592.
29. Hofmann AF, Zakko SF, Lira M, Clerici C, Hagey LR, Lambert KK, et al. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology 2005;42:1391-1398.
30. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 2008;48:2064-2077.
31. Masumoto T, Masuoka S. Kidney function in the severely jaundiced dog. Am J Surg 1980;140:426-430.
32. Schlattjan JH, Winter C, Greven J. Regulation of renal tubular bile acid transport in the early phase of an obstructive cholestasis in the rat. Nephron Physiol 2003;95:49-56.
33. Kaler B, Karram T, Morgan WA, Bach PH, Yousef IM, Bomzon A. Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats. Ren Fail 2004;26:507-516.
34. Gregus Z, Klaassen CD. Comparison of Biliary excretion of organic anions in mice and rats. Toxicol Appl Pharmacol 1982;63:13-20.
35. Pollheimer MJ, Trauner M, Fickert P. Will we ever model PSC?-"It's hard to be a PSC model!". Clin Res Hepatol Gastroenterol 2011;35:792-804.
36. Fickert P, Stöger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007;171:525-536.
37. Sommerfeld A, Reinehr R, Haussinger D. Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem 2009;284:22173-22183.
38. Fickert P, Fuchsbichler A, Moustafa T, Wagner M, Zollner G, Halilbasic E, et al. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am J Pathol 2009;175:2392-2405.
39. Luo B, Tang L, Wang Z, Zhang J, Ling Y, Feng W, et al. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 2005;129:682-695.
40. Shah N, Dhar D, El Zahraa Mohammed F, Habtesion A, Davies NA, Jover-Cobos M, et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol 2012;56:1047-1053.
41. Walker JG. Renal failure in jaundice. Proc R Soc Med 1962;55:570.
42. Dawson JL. Acute post-operative renal failure in obstructive jaundice. Ann R Coll Surg Engl 1968;42:163-181.
43. Clairmont P. Mitteilung über Anurie nach Gallensteinoperationen. [Communication on anuria after gallstone surgery.] Grenzgeb Med Chir 1911;22:159.
44. Neuhaus TJ, Stallmach T, Leumann E, Altorfer J, Braegger CP. Familial progressive tubulo-interstitial nephropathy and cholestatic liver disease-a newly recognized entity? Eur J Pediatr 1997;156:723-726.
45. Proesmans W, van Damme B, Desmet V, Eeckels R. Fatal tubulo-intestitial nephropathy with chronic cholestatic liver disease. Acta Paediatr Belg 1976;29:231-238.
46. Harris HW, Jr., Carpenter TO, Shanley P, Rosen S, Levey RH, Harmon WE. Progressive tubulointerstitial renal disease in infancy with associated hepatic abnormalities. Am J Med 1986;81:169-176.
47. Tekin N, Durmuş-Aydoǧdu S, Dinleyici EC, Bör O, Bildirici K, Akşit A. Clinical and pathological aspects of ARC (arthrogryposis, renal dysfunction, and cholestasis) syndrome in two siblings. Turk J Pediatr 2005;47:67-70.
48. Papadia F, Pollice L, Natale B, Bellantuono R, Conti P, Carnevale F. Biliary malformation with renal tubular insufficiency in two male infants: third family report. Clin Genet 1996;49:267-270.
49. Mikati MA, Barakat AY, Sulh HB, Der Kaloustian VM. Renal tubular insufficiency, cholestatic jaundice, and multiple congenital anomalies-a new multisystem syndrome. Helv Paediatr Acta 1984;39:463-471.
50. Altamirano J, Fagundes C, Dominguez M, García E, Michelena J, Cárdenas A, Guevara M, et al. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 2012;10:65-71.
51. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45:1348-1354.